FindTrial
Sign In

A randomized comparative study to evaluate additive effect of Guduchi ghan vati along with Jalaukavacharana in Episcleritis.

A randomized clinical comparative study to evaluate the effect of Jalaukavacharana with Guduchi ghanvati and Jalaukavacharana in Sirajaal with special reference to Episcleritis.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/12/022343
Enrollment
62
Registered
2019-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H151- Episcleritis

Interventions

Intervention1: Guduchi Ghan Vati along with Jalaukavacharana: Jalaukavacharan at apang Pradesh of affected eye(2 sittings/week- at least 7sittings ) and abhyantar prayog of Guduchi ghanvati(for 3 mon

Sponsors

HOD Shalakyatantra Dept RAPodar Med College Worli Mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: between 18 to 50 years. 2. Sex: male and female â?? both included. 3. Disease â??Episcleritis. 4. Patient not dependent on steroids. 5. Patient with controlled diabetes mellitus (fasting- 70 to 110, post- prandial -110 to 140mg/dl) and controlled hypertension (systolic blood pressure -110 to 140mmHg, diastolic blood pressure- 70 to 90mm Hg).

Exclusion criteria

Exclusion criteria: 1. Blood disorder like sickle cell anemia, hemophilia. 2. Steroid dependent patient. 3. Patient suffering from HIV, HbsAg, Kochâ??s. 4. Uncontrolled DM and uncontrolled hypertension. 5. Active infections â?? ocular diseases. 6. Pregnant women and lactating mother. 7. Patient suffering from psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
â?¢ To evaluate the efficacy of Jalaukavacharana and Guduchi ghanvati in Sirajaal with special reference to Episcleritis.Timepoint: â?¢ To evaluate the efficacy of Jalaukavacharana and Guduchi ghanvati in Sirajaal with special reference to Episcleritis by the end of 3 months.—

Secondary

MeasureTime frame
To evaluate the efficacy of Jalaukavacharana and Guduchi ghanvati in Episcleritis using the criteria congestion , pain & nodular swelling.Timepoint: To evaluate the efficacy of Jalaukavacharana and Guduchi ghanvati in Episcleritis using the criteria congestion , pain & nodular swelling after time period of 3 months.—

Countries

India

Contacts

Public ContactDr Adarsh Sharma

R.A.Podar Med.(Ayu) College , Worli , Mumbai

dramrut16@gmail.com9819139017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026